These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9359727)

  • 101. Dual orientation of the outer membrane lipoprotein Pal in Escherichia coli.
    Michel LV; Shaw J; MacPherson V; Barnard D; Bettinger J; D'Arcy B; Surendran N; Hellman J; Pichichero ME
    Microbiology (Reading); 2015 Jun; 161(6):1251-9. PubMed ID: 25808171
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Characterization of surface proteins of Cronobacter muytjensii using monoclonal antibodies and MALDI-TOF Mass spectrometry.
    Jaradat ZW; Rashdan AM; Ababneh QO; Jaradat SA; Bhunia AK
    BMC Microbiol; 2011 Jun; 11():148. PubMed ID: 21702985
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Virulence and immunomodulatory roles of bacterial outer membrane vesicles.
    Ellis TN; Kuehn MJ
    Microbiol Mol Biol Rev; 2010 Mar; 74(1):81-94. PubMed ID: 20197500
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Vesicle-independent extracellular release of a proinflammatory outer membrane lipoprotein in free-soluble form.
    Karched M; Ihalin R; Eneslätt K; Zhong D; Oscarsson J; Wai SN; Chen C; Asikainen SE
    BMC Microbiol; 2008 Jan; 8():18. PubMed ID: 18226201
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis.
    Valentine CH; Hellman J; Beasley-Topliffe LK; Bagchi A; Warren HS
    Mol Med; 2006; 12(9-10):252-8. PubMed ID: 17225874
    [TBL] [Abstract][Full Text] [Related]  

  • 106. A model of infected burn wounds using Escherichia coli O18:K1:H7 for the study of gram-negative bacteremia and sepsis.
    Busch NA; Zanzot EM; Loiselle PM; Carter EA; Allaire JE; Yarmush ML; Warren HS
    Infect Immun; 2000 Jun; 68(6):3349-51. PubMed ID: 10816484
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum.
    Hellman J; Loiselle PM; Tehan MM; Allaire JE; Boyle LA; Kurnick JT; Andrews DM; Sik Kim K; Warren HS
    Infect Immun; 2000 May; 68(5):2566-72. PubMed ID: 10768945
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5.
    Baumgartner JD; O'Brien TX; Kirkland TN; Glauser MP; Ziegler EJ
    J Infect Dis; 1987 Jul; 156(1):136-43. PubMed ID: 2439613
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Release of gram-negative outer-membrane proteins into human serum and septic rat blood and their interactions with immunoglobulin in antiserum to Escherichia coli J5.
    Hellman J; Loiselle PM; Zanzot EM; Allaire JE; Tehan MM; Boyle LA; Kurnick JT; Warren HS
    J Infect Dis; 2000 Mar; 181(3):1034-43. PubMed ID: 10720528
    [TBL] [Abstract][Full Text] [Related]  

  • 110. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.
    Trautmann M; Hahn H
    Infection; 1985; 13(3):140-5. PubMed ID: 3897069
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria.
    Hellman J; Zanzot EM; Loiselle PM; Amato SF; Black KM; Ge Y; Kurnick JT; Warren HS
    J Infect Dis; 1997 Nov; 176(5):1260-8. PubMed ID: 9359727
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Antiserum treatment of gram-negative bacteremia.
    Braude AI; Ziegler EJ; McCutchan JA
    Schweiz Med Wochenschr; 1978 Dec; 108(48):1872-6. PubMed ID: 362528
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Reactivity of antibodies to core glycolipid with gram-negative bacteria.
    Shenep JL; Gigliotti F; Davis DS; Hildner WK
    Rev Infect Dis; 1987; 9 Suppl 5():S639-43. PubMed ID: 2446371
    [TBL] [Abstract][Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.